Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ASPCF - Acerus Pharmaceuticals Corporation's (ASPCF) CEO Ed Gudaitis on Q4 2021 Results - Earnings Call Transcript

ASPCF - Acerus Pharmaceuticals Corporation's (ASPCF) CEO Ed Gudaitis on Q4 2021 Results - Earnings Call Transcript

Acerus Pharmaceuticals Corp
Acerus Pharmaceuticals Corporation (ASPCF) Q4 2021 Earnings Conference Call March 15, 2022 10:00 AM ET Company Participants Bob Motz - Chief Financial Officer Ed Gudaitis - President and CEO Conference Call Participants Presentation Operator Good morning, ladies and gentlemen, and welcome to the Q4 2021 Conference Call for Acerus Pharmaceuticals Corporation. At this time all participants are in listen-only mode. A brief Question-And-Answer Session will follow this discussion. [Operator Instructions] As a reminder, this conference is being recorded. It will be available for replay until 11:59 p.m. on Tuesday, March 22, 2022, by dialing (905) 694-9451 or 1 (800) 408-3053, using access code 6591972#. I will now turn the call over to Mr. Bob Motz, Chief Financial Officer of Acerus Pharmaceuticals Corporation. Mr. Motz will moderate today’s call. Mr. Motz, please proceed. Bob Motz Thank you very much, operator. Good morning to everyone, and welcome to the Acerus 2021 fourth

For further details see:

Acerus Pharmaceuticals Corporation's (ASPCF) CEO Ed Gudaitis on Q4 2021 Results - Earnings Call Transcript
Stock Information
Company Name: Acerus Pharmaceuticals Corp
Stock Symbol: ASPCF
Market: OTC
Website: aceruspharma.com
Menu
ASPCF ASPCF Quote ASPCF Short ASPCF News ASPCF Articles ASPCF Message Board
Get ASPCF Alerts

News, Short Squeeze, Breakout and More Instantly...